The next big winner in 2013.
TTNP was granted priority review by the FDA with a PDUFA date of April 30.
TTNP has a 6 month slow release medication for the huge addiction market.
There are millions of Americans addicted to illicit drugs and pain meds.
TTNP will receive a milestone payment of $50,000,000.00 on approval.
Pick up some shares, you won't regret it.
Unload a stock in a downtrend.
Buy a stock in an uptrend.